Medicine | Oncology
Prostate cancer
Treatment
High-risk localized prostate cancer


Home > Disciplines > Medicine > Oncology > Prostate cancer > Treatment > High-risk localized prostate cancer



Contents



Overview
Laboratory Investigations
Clinical investigations
Newly diagnosed tumors
Recurrent tumors
Miscellanea



Overview



Cheng X, Wang ZH, Peng M, Huang ZC, Yi L, Li YJ, Yi L, Luo WZ, Chen JW, Wang YH.
The role of radical prostatectomy and definitive external beam radiotherapy in combined treatment for high-risk prostate cancer: a systematic review and meta-analysis.
Asian J Androl. 2019 Oct 8. doi: 10.4103/aja.aja_111_19. [Epub ahead of print]
Source . Similar articles



.

Fonteyne V, Ost P.
Current Insights in the Management of High-risk Prostate Cancer: Still More Questions than Answers.
Eur Urol. 2018 Aug 30. pii: S0302-2838(18)30598-0. doi: 10.1016/j.eururo.2018.08.013. [Epub ahead of print]
Source | Full text | Similar articles
Comment on: Tosco L et al, Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer. Eur Urol. 2018 Oct 1. pii: S0302-2838(18)30549-9. doi: 10.1016/j.eururo.2018.07.027. [Epub ahead of print]. Source , Full text



.

Sundi D, Chapin BF.
Very-high-risk (VHR) localized prostate cancer: an indication for multimodal therapy.
Oncotarget. 2019 Mar 8;10(20):1870-1871. doi: 10.18632/oncotarget.26757. eCollection 2019 Mar 8.
Source | Full text | Similar articles



.

Tosco L, Briganti A, D'amico AV, Eastham J, Eisenberger M, Gleave M, Haustermans K, Logothetis CJ, Saad F, Sweeney C, Taplin ME, Fizazi K.
Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer.
Eur Urol. 2018 Oct 1. pii: S0302-2838(18)30549-9. doi: 10.1016/j.eururo.2018.07.027. [Epub ahead of print]
Source | Full text | Similar articles



Laboratory investigations




Clinical investigations




Newly diagnosed tumors



Enokida H, Yamada Y, Tatarano S, Yoshino H, Yonemori M, Sakaguchi T, Nishimura H, Eura R, Nakagawa M.
Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm study.
Jpn J Clin Oncol. 2019 Oct 28. pii: hyz138. doi: 10.1093/jjco/hyz138. [Epub ahead of print]
Source . Similar articles



Recurrent tumors




Miscellanea